Polaryx Therapeutics, Inc. (PLYX) › Cash & EquivalentsPolaryx Therapeutics, Inc. (PLYX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $4.62M2025: $5.14M$5.14M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$5.14M+11.3%2024$4.62M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share